Suramin: an anticancer drug with unique biological effects
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Link
http://link.springer.com/content/pdf/10.1007/BF00685609.pdf
Reference36 articles.
1. Betsholtz C, Johnsson A, Heldin CH, Westermark B (1986) Efficient reversion of simian sarcoma virus transformation and inhibition of growth factor-induced mitogenesis by suramin. Proc Natl Acad Sci USA 83:6440
2. Bojanowski K, Lelievre S, Markovits J, Couprie J, Jacquemin-Sablon A, Larsen AK (1992) Suramin is an inhibitor of DNA topoisomerase II in vitro and in Chinese hamster sarcoma cells. Proc Natl Acad Sci USA 89:3025
3. Butler SJ, Kelly CH, McKenzie FR, Guild SB, Wakelam MJO, Milligan G (1988) Differential effects of suramin on the coupling of receptors to individual species of pertussis-toxin-sensitive guaninenucleotide-binding proteins. Biochem J 251:201
4. Calcaterra NB, Vicario LR, Roveri OA (1988) Inhibition by suramin of mitochondrial ATP synthesis. Biochem Pharmacol 37:2521
5. Cheson BD, Levine AM, Mildvan D, Kaplan LD, Wolfe P, Rios A, Groopman JE, Gill P, Volberding PA, Poiesz BJ, Gottlieb MS, Holden H, Volsky DJ, Silver SS, Hawkins MJ (1987) Suramin therapy in AIDS and related disorders. Report of the US Suramin Working Group. JAMA 258:1347
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. HMM-based profiling identifies the binding to divalent cations and nucleotides as common denominators of suramin targets;Frontiers in Drug Discovery;2023-02-10
2. Structural Basis of Inhibition of the Pioneer Transcription Factor NF-Y by Suramin;Cells;2020-10-29
3. Direct High‐Throughput Screening Assay for mRNA Cap Guanine‐N7 Methyltransferase Activity;Chemistry – A European Journal;2020-08-10
4. A small-molecule screen identifies the antitrypanosomal agent suramin and analogues NF023 and NF449 as inhibitors of STAT5a/b;Bioorganic & Medicinal Chemistry Letters;2017-08
5. A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers;Cancers;2016-07-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3